[go: up one dir, main page]

GB202400295D0 - Hypertonic thermostable vaccine compositions - Google Patents

Hypertonic thermostable vaccine compositions

Info

Publication number
GB202400295D0
GB202400295D0 GBGB2400295.8A GB202400295A GB202400295D0 GB 202400295 D0 GB202400295 D0 GB 202400295D0 GB 202400295 A GB202400295 A GB 202400295A GB 202400295 D0 GB202400295 D0 GB 202400295D0
Authority
GB
United Kingdom
Prior art keywords
hypertonic
vaccine compositions
thermostable vaccine
thermostable
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2400295.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STABLEPHARMA Ltd
Original Assignee
STABLEPHARMA Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STABLEPHARMA Ltd filed Critical STABLEPHARMA Ltd
Priority to GBGB2400295.8A priority Critical patent/GB202400295D0/en
Publication of GB202400295D0 publication Critical patent/GB202400295D0/en
Priority to PCT/EP2024/061655 priority patent/WO2025149184A1/en
Priority to PCT/EP2025/050487 priority patent/WO2025149594A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB2400295.8A 2024-01-09 2024-01-09 Hypertonic thermostable vaccine compositions Ceased GB202400295D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB2400295.8A GB202400295D0 (en) 2024-01-09 2024-01-09 Hypertonic thermostable vaccine compositions
PCT/EP2024/061655 WO2025149184A1 (en) 2024-01-09 2024-04-26 Hypertonic thermostable vaccine compositions
PCT/EP2025/050487 WO2025149594A1 (en) 2024-01-09 2025-01-09 Hypertonic thermostable vaccine compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2400295.8A GB202400295D0 (en) 2024-01-09 2024-01-09 Hypertonic thermostable vaccine compositions

Publications (1)

Publication Number Publication Date
GB202400295D0 true GB202400295D0 (en) 2024-02-21

Family

ID=89901432

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2400295.8A Ceased GB202400295D0 (en) 2024-01-09 2024-01-09 Hypertonic thermostable vaccine compositions

Country Status (2)

Country Link
GB (1) GB202400295D0 (en)
WO (2) WO2025149184A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995033488A1 (en) 1994-06-02 1995-12-14 Quadrant Holdings Cambridge Limited Method of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby
KR20030020294A (en) * 2000-06-08 2003-03-08 파우더젝트 백신, 인코포레이티드 Powder Compositions

Also Published As

Publication number Publication date
WO2025149184A1 (en) 2025-07-17
WO2025149594A1 (en) 2025-07-17

Similar Documents

Publication Publication Date Title
GB202400295D0 (en) Hypertonic thermostable vaccine compositions
GB202411091D0 (en) Compositions and uses
GB202316199D0 (en) Compositions and methods and uses thereto
GB202205231D0 (en) Vaccine compositions
IL317503A (en) Risankizumab compositions
GB202215065D0 (en) Compositions and uses thereof
GB202209335D0 (en) Compositions and uses thereof
GB202418850D0 (en) Immunogenic compositions
GB202409272D0 (en) Immunogenic compositions
GB202416789D0 (en) SARS-COV-2 immunogenic compositions
GB202315018D0 (en) Immunogenic compositions
GB202204478D0 (en) Immunogenic compositions
GB202204482D0 (en) Immunogenic compositions
GB202203250D0 (en) Immunogenic compositions
GB202314361D0 (en) Vaccine compositions and uses thereof
GB202506177D0 (en) Denaturation compositions
GB202313652D0 (en) Immunogenic composition
GB202302579D0 (en) Immunogenic composition
GB202208093D0 (en) Immunogenic composition
GB202511471D0 (en) Exosome-based compositions
GB202505602D0 (en) Compositions
GB202500743D0 (en) Compositions
GB202411739D0 (en) Compositions
GB202409569D0 (en) Compositions
GB202411057D0 (en) Compositions and uses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)